Results 21 to 30 of about 31,827 (245)

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Liver transplantation for polycystic liver disease [PDF]

Liver Transplantation, 2001
Polycystic liver disease (PLD) may provoke massive hepatomegaly and severe physical and social handicaps. Data on orthotopic liver transplantation (OLT) for PLD are rare and conflicting. Conservative surgery (resection or fenestration) is indicated for large single cysts, but its value for small diffuse cysts is questionable ...
J, Pirenne, R, Aerts, K, Yoong, B, Gunson, T, Koshiba, I, Fourneau, D, Mayer, J, Buckels, D, Mirza, T, Roskams, E, Elias, F, Nevens, J, Fevery, P, McMaster   +13 more
openaire   +2 more sources

Proliferation-Independent Initiation of Biliary Cysts in Polycystic Liver Diseases. [PDF]

PLoS ONE, 2015
Biliary cysts in adult patients affected by polycystic liver disease are lined by cholangiocytes that proliferate, suggesting that initiation of cyst formation depends on proliferation.
Jean-Bernard Beaudry, Sabine Cordi, Céline Demarez, Sébastien Lepreux, Christophe E Pierreux, Frédéric P Lemaigre   +5 more
doaj   +1 more source

Liver Transplantation for Polycystic Liver Disease [PDF]

Archives of Surgery, 1990
Four female patients with severe complications of polycystic liver disease were treated with liver replacement; two patients were also given kidneys from their liver donors. All four of the patients were suffering from extreme fatigue. Three of the recipients have survived for 8, 11, and 60 months with normal liver function and present good health. The
Starzl, TE, Reyes, J, Tzakis, A, Mieles, L, Todo, S, Gordon, R   +5 more
openaire   +2 more sources

Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?

Archives of Endocrinology and Metabolism, 2019
Objective: Nonalcoholic fatty liver disease is the commonest diffuse liver disease, of which women with polycystic ovary syndrome are at an increased risk.
Na Di, Xinchuan Zhou, Yaxiao Chen, Xiaomiao Zhao, Lin Li, Linlin Jiang, Baoming Luo, Xiaoli Chen, Dongzi Yang   +8 more
doaj   +1 more source

Polycystic liver disease: a clinical review

Annals of Hepatology, 2012
Polycystic liver disease rarely occurs in isolation as part of autosomal dominant polycystic liver disease, but more commonly, it exists as an extra-renal manifestation of autosomal dominant polycystic kidney disease. The pathogenesis of polycystic liver
Natasha Chandok, M.D., MPH, FRCPC
doaj   +1 more source

Polycystic liver disease presenting with an exudative pleural effusion: a case report

Journal of Medical Case Reports, 2012
Introduction Polycystic liver disease is asymptomatic in 95% of patients. In the remaining 5% it causes symptoms due to the local mass effect of the polycystic liver. We describe the case of a patient who presented with symptoms of a pleural effusion and
Woolnough Kerry, Palejwala Altav, Bramall Simon   +2 more
doaj   +1 more source

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease

BMC Nephrology, 2012
Background A large proportion of patients with autosomal dominant polycystic kidney disease (ADPKD) suffers from polycystic liver disease. Symptoms arise when liver volume increases.
Gevers Tom JG, Chrispijn Melissa, Wetzels Jack FM, Drenth Joost PH   +3 more
doaj   +1 more source

Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results

Annals of Hepatology, 2013
Background. Non-total liver resecting invasive treatment of polycystic liver disease has different recurrence rates. The aim of this study is to illustrate why the recurrence rates are different.
Zheng Long-Xian, Liu Ai-Wu, Qin Hua-Dong, Cui Jun, Jiang Hui-Jie, Jia Hong-Bo   +5 more
doaj   +1 more source

Isolated Polycystic Liver Disease [PDF]

Advances in Chronic Kidney Disease, 2010
Isolated polycystic liver disease (PCLD) is an autosomal dominant disease with genetic and clinical heterogeneity. Apart from liver cysts, it exhibits few extrahepatic manifestations, and the majority of patients with this condition are asymptomatic or subclinical.
openaire   +2 more sources